The QualityStocks Daily Stock List
- Corvus Gold, Inc. (CORVF)
- Critical Elements Lithium Corporation (CRECF)
- Fission Uranium Corp. (FCUUF)
- Gold Springs Resource Corp. (GRCAF)
- Golden Matrix Group, Inc. (GMGI)
- Humanigen, Inc. (HGEN)
- Sonoma Pharmaceuticals, Inc. (SNOA)
- Star Navigation Systems Group Ltd. (SNAVF)
- Notox Technologies Corp. (NTOX)
- FieldPoint Petroleum Corp. (FPPP)
- Select Sands Corp. (SLSDF)
- Adama Technologies Corporation (ADAC)
- Sunset Island Group, Inc. (SIGO)
- Cavitation Technologies, Inc. (CVAT)
Corvus Gold, Inc. (CORVF)
NetworkNewsWire, Zacks, The Prospector News, Investing News, Stockhouse, GuruFocus, Real Investment Advice, Wallet Investor, Junior Mining Network, The Daily Gold, MineStat, Street Insider, Research Pool, Stock News Now, Stock Digest, InvestorsHub, Trading View, Investors Hangout, and Morningstar reported earlier on Corvus Gold, Inc. (CORVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Corvus Gold, Inc. acquires, explores, and develops mineral properties chiefly in the U.S. The Company’s mandate is to become a foremost exploration and development enterprise with the ultimate aim of becoming a non-operating gold producer with considerable carried interest and royalty exposure. Its main mineral property is the North Bullfrog Project. This is a gold-silver mining project in northwestern Nye County, Nevada. OTCQX-listed, Corvus Gold is headquartered in Vancouver, British Columbia.
The North Bullfrog Project comprises leased, patented, and unpatented mining claims encompassing an area of approximately 86.6 km2 consisting of a mix of private mineral leases of patented federal mining claims and 1,057 federal unpatented mining claims. The Project is 10 km north of Beatty, Nevada, and 8 km north of the Bullfrog Mine previously operated by Barrick Gold Corporation.
The North Bullfrog Project represents a large, low-sulphidation, epithermal bulk-tonnage gold system hosted in volcanic and sedimentary rocks. The project is 100 percent controlled by Corvus Gold.
The Company also has its Mother Lode Project. This Project is 165 km northwest of Las Vegas, Nevada, 10 km east of Beatty, Nevada, and roughly 20 road km’s from Corvus Gold’s North Bullfrog project in the Walker Land gold belt. The Mother Lode Project consists of 445 federal unpatented mining claims encompassing an area of about 36.5 km².
Today, Corvus Gold announced it received initial assay results from its Phase-4 Mother Lode resource expansion drilling program . Both holes returned positive results from the southwest part of the deposit where Main Zone mineralization has now extended to the southwest part of the resource area. The Company’s belief is that this Southwestern extension of higher-grade mineralization has demonstrated potential for the deposit to continue expansion in multiple directions and now at depth with hole ML19-119 intersecting 50.3m @ 1.50 g/t gold in a newly identified intrusive zone.
Mr. Jeffrey Pontius, President and Chief Executive Officer of Corvus Gold, said, “The new Phase-4 results at Mother Lode has begun where we left off earlier this year, by successfully expanding the deposit with thick, higher-grade Main Zone mineralization. Additionally, the discovery of a new deep intrusive related zone is exciting as it may be the first indicator of a significant new gold system below the main Mother Lode deposit as outlined by our new geophysical target.
Corvus Gold, Inc. (CORVF), closed Thursday's trading session at $1.4948, up 6.7714%, on 58,251 volume with 49 trades. The average volume for the last 3 months is 35,228 and the stock's 52-week low/high is $1.12999999/$2.20000004.
Critical Elements Lithium Corporation (CRECF)
Energy and Capital, GuruFocus, Stockhouse, Investor Intel, Investing News, Morningstar, Junior Mining Network, Equities.com, Mining Stock Education, SmallCapPower, Geology for Investors, Mining.com, Nasdaq, GlobeNewswire, PR Newswire, Miningandenergy.ca. Otc.watch, TradingView, InvestorsHub, Simply Wall St and Seeking Alpha reported earlier on Critical Elements Lithium Corporation (CRECF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Based in Montreal, Quebec, Critical Elements Lithium Corporation is a junior mining company in advanced exploration stage. Its flagship project is the Rose Lithium-Tantalum project positioned in James Bay, Quebec. Critical Elements Lithium owns a number of mining properties in Quebec and its emphasis is lithium. The Company previously went by the name Critical Elements Corporation. It changed its name to Critical Elements Lithium Corporation in June of this year.
The Rose Lithium-Tantalum project has a good geographic location and on-site access to infrastructures such as powerline, roads, airport, railway access and camp. The Rose property consists of 473 claims spread over a 24,654.81 ha area. Based on the work programs developed and positive results, Critical Elements Lithium is working to put the Rose Lithium-Tantalum project into production quickly. At present, the Rose Lithium-Tantalum Project contains reserves of 26,8 million tonnes of Probable Reserves at a grade of 0.96% Li2O Eq. or 0.85% Li2O and 133 ppm Ta2O5.
Critical Elements Lithium’s development strategy is based on a proven Management Team; a low risk two-phase approach; and a simple open pit mining and conventional processing operation. Phase 1 captures 70 percent of the value - Phase 1 production of spodumene concentrate and tantalum; Phase 2 production of lithium carbonate.
Recently, Critical Elements Lithium announced that Primero Group successfully completed the first phase of its Early Contractor Involvement (ECI) agreement with Critical Elements, and that Primero provided a Guaranteed Maximum Price (GMP) for the engineering, procurement and construction (EPC) of the Rose Lithium-Tantalum project on a lump sum turnkey basis, which is in line with the Project’s Feasibility Study published November 29, 2017.
Critical Elements and Primero are in discussions to start the second phase of the ECI agreement (ECI Phase II – Front End Engineering Design) that will include initial detailed engineering and determining fixed prices based on the GMP for Primero to perform all of the work involved in completing the EPC lump sum turnkey proposal. In addition, Primero is offering Critical Elements its EPC services as a fully integrated package if the final lump sum is within the GMP, and if technical and commercial parameters are met during the second phase. Primero provides engineering design, construction and operational services to the minerals, energy and infrastructure sectors.
Critical Elements Lithium Corporation (CRECF), closed Thursday's trading session at $0.3711, even for the day, on 275 volume. The average volume for the last 3 months is 14,537 and the stock's 52-week low/high is $0.200000002/$0.628499984.
Fission Uranium Corp. (FCUUF)
Zacks, Wealth Daily, Stock News Now, Metals News, Resource Stock Digest, Macroaxis, TipRanks, Junior Mining Network, GuruFocus, Energy and Capital, Streetwise Reports, Wallet Investor, Resource World, InvestorsHub, Nasdaq, and Stockhouse reported beforehand on Fission Uranium Corp. (FCUUF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
OTCQX-listed, Fission Uranium Corp. engages in the exploration and development of uranium properties. It 100 percent owns the award-winning PLS (Patterson Lake South) uranium project, host to the near-surface, high-grade Triple R deposit - part of the largest mineralized trend in the Athabasca Basin area. Since discovery in 2012, significant new high-grade zones have been discovered each year. Recently, exploration drilling encountered mineralization 600m west of the trend. Fission Uranium has its corporate office in Kelowna, British Columbia.
The Company is concentrating on continued exploration at the large and highly-prospective PLS project and further development of the Triple R deposit. Patterson Lake South (PLS) is host to the abovementioned Triple R deposit - the most significant high grade shallow depth deposit in the area. The Triple R deposit is open in multiple directions, particularly westwards, towards the high-grade boulder field. A preliminary economic study conducted in 2015 shows the Triple R has the potential for an OPEX of $14.02/lb. This would make it one of the world's lowest cost uranium producers.
The PLS Property comprises 17 mineral claims totaling 31,039 ha positioned on the southwest margin of the Athabasca Basin. The property is accessible by all-weather Highway 955 that continues north through the area of the UEX-AREVA Shea Creek deposits to the past producing Cluff Lake uranium mine.
In November, Fission Uranium announced that it filed a technical report on the Triple R Deposit at its PLS project in Canada's Athabasca Basin, pursuant to National Instrument 43-101 "Standards of Disclosure for Mineral Projects" (NI 43-101). The Report summarizes the Pre-Feasibility Study (UG PFS) that outlines an underground-only mining scenario for PLS and follows an earlier PFS report outlining a combination of open pit and underground techniques (the Hybrid PFS).
Report highlights include cost and time savings and a minimized footprint - mine-related earth movement from the Hybrid PFS to the U/G PFS is lessened by 90 percent, leading to a minimized surface footprint. Highlights also include strong economics - a projected OPEX of just US$7.18 /lb, an IRR (pre-tax) of 34 percent and an NPV (pre-tax) at 8 percent of $1.33B , therefore outlining the potential for highly economic production at PLS.
Furthermore, report highlights also include a clear path to growth – the ability to easily accommodate more material from the three high-grade zones outside of the present mine plan, leading to a potential increase in resource size and mine life.
Fission Uranium Corp. (FCUUF), closed Thursday's trading session at $0.205, up 0.195503%, on 139,062 volume with 32 trades. The average volume for the last 3 months is 198,404 and the stock's 52-week low/high is $0.200000002/$0.459899991.
Gold Springs Resource Corp. (GRCAF)
StockCharts, SmallCapPower, OTC Markets, Wallet Investor, TMXmoney, Dividend.com, TradingView, GlobeNewswire, MarketScreener, InvestingNote, Dividend Investor, MarketWatch, Investors Hangout, Stockhouse, and InvestorsHub reported previously on Gold Springs Resource Corp. (GRCAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Gold Springs Resource Corp. is a gold exploration company creating value via the exploration and development of the Gold Springs Project in Nevada and Utah. Its Management has wide-ranging experience in worldwide exploration and the mining industry. The Company previously went by the name TriMetals Mining, Inc. It changed its name to Gold Springs Resource Corp. last month. OTCQB-listed and incorporated in 2006, Gold Springs Resource has its corporate headquarters in Vancouver, British Columbia.
The Gold Springs Project is situated in the prolific Great Basin of Western USA, in one of the best mining jurisdictions globally. The Company’s belief is that Gold Springs has the potential to host multimillion-ounce gold and silver resources. Ownership of the Gold Springs Project is 100 percent Gold Springs Resource Corp.
Gold Springs is an advanced exploration stage gold project that straddles eastern Lincoln County, Nevada, and western Iron County, Utah – the abovementioned Great Basin of Western USA. The Project has multiple targets with four resource zones (North Jumbo, South Jumbo, Grey Eagle and Thor) open for expansion.
It has shallow open pit, low sulphidation, heap leach potential. Regarding the Project’s outlook, it is a district-scale property with medium-term potential with drilling for resource upgrade and expansion at the Jumbo Trend and for identification of high-grade mineralization at the new Homestake Target. The Gold Springs Project encompasses roughly 7,847 hectares, consisting of of federal lode claims, Utah State leases, and patented mining claims held through leases and purchases.
The Company's emphasis for 2019 and beyond is on the exploration and expansion of the mineral resources at its Gold Springs Project. The priority targets are to extend the North Jumbo and South Jumbo towards each other along a 5.5-kilometer Jumbo Trend.
The Gold Springs Project encompasses a number of historical mining districts. These include the Deer Lodge, Fay, and the Eagle Valley districts, all within Nevada, and the Gold Springs District in Utah. The project area contains hundreds of historical workings that began around 1897 with several mines that produced gold intermittently until the early 1940s.
Gold Springs Resource Corp. (GRCAF), closed Thursday's trading session at $0.1271, up 5.9167%, on 21,210 volume with 10 trades. The average volume for the last 3 months is 30,312 and the stock's 52-week low/high is $0.019999999/$0.127100005.
Golden Matrix Group, Inc. (GMGI)
Stock Muse, TraderNewsWire, OTC Markets, Real Investment Advice, TipRanks, Simply Wall St, Wallet Investor, InvestorsHub, Market Screener, 4-Traders, Nasdaq, Stockhouse, TradingView, Last10k, Dividend Investor, Stockopedia, GlobeNewswire, and Infront Analytics reported earlier on Golden Matrix Group, Inc. (GMGI), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Golden Matrix Group, Inc. designs and develops social gaming platforms, systems and gaming content. A technology-driven business, it develops and owns online gaming IP (Intellectual Property) and builds configurable and scalable white-label social gaming platforms for its worldwide customers, located chiefly in the Asia Pacific region. The Company was formerly known as Source Gold Corp. It changed its name to Golden Matrix Group, Inc. in March 2016. Formed in 2008, Golden Matrix Group is headquartered in Las Vegas, Nevada.
Golden Matrix pioneers highly modular, configurable, and scalable social gaming platforms for its customers. This is to promote user acquisition, engagement, retention, and monetization. Its platform enhances clients’ ability to cater to diverse gaming scenarios. This includes, but is not limited to, transaction management and a range of loyalty/reward programs. Furthermore, user engagement is optimized by way of the Company’s ability to accommodate free and cost to play games.
Golden Matrix derives its revenues primarily from licensing fees received from gaming operators located in the Asia Pacific (APAC) region and integrated with its state-of-the-art GM-X platform. Concerning its Services, the Company has a completely operational platform. The platform delivers all features and services required to introduce a white label social gaming site. Golden Matrix offers Management services. It has a single suite of integrated applications to collect, store, manage, as well as interpret real-time gaming data.
Services include incentivising users with credits, prizes and rewards. As a result, this enhances user engagement and retention. In addition, the Company provides access to premier games across in-demand gaming genres. It also provides updates – the continual updating of gaming features and the addition of new games to reduce content sourcing. Golden Matrix’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with present United States law.
Today, Golden Matrix Group announced that for the first fiscal (2020) quarter ended October 31, 2019, it reported Net Income of $545,888, a 64.4 percent increase on Net Income of $331,999 in the first fiscal quarter ended October 31, 2018. Record Revenues of $881,845 in fiscal Q1’20 represent a 38.1 percent improvement on Revenues of $638,695 in fiscal Q1’19. Net Profit Margin was 62 percent in fiscal Q1’20 in comparison to 52 percent in the like year-ago quarter.
Golden Matrix Group Chief Executive Officer, Mr. Brian Goodman, said “Our impressive accelerating growth can be attributed primarily to introductions - over the past year - of exciting proprietary and exclusive gaming content on our powerful GM-X platform, which in turn has led to meaningful increases in the number of operators and active users.”
Golden Matrix Group, Inc. (GMGI), closed Thursday's trading session at $0.005, up 6.383%, on 3,503,606 volume with 45 trades. The average volume for the last 3 months is 2,213,565 and the stock's 52-week low/high is $0.00095/$0.0073.
Humanigen, Inc. (HGEN)
NetworkNewsWire, 4-Traders, Trading View, Investors Hangout, Whale Wisdom, TipRanks, Proactive Investors, Stockopedia, GlobeNewswire, InvestorsHub, Insider Financial, Morningstar, Stockhouse, StreetWise Reports, Street Insider, Equity Clock, Barchart, and Proactive Investors reported beforehand on Humanigen, Inc. (HGEN), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Humanigen, Inc. is developing its Humaneered® proprietary monoclonal antibodies to address critical unmet needs in today's most advanced cancer therapies. A biopharmaceutical Company, it is developing its portfolio of Humaneered® monoclonal antibodies focused on CAR-T optimization and immuno-oncology. Humaneering is a patented proprietary technology for converting suboptimal antibodies into human antibodies suitable for chronic therapies, in part, due to low immunogenicity. The Company formerly went by the name KaloBios Pharmaceuticals, Inc. It changed its corporate name to Humanigen, Inc. in August 2017. Humanigen has its corporate office in Burlingame, California.
Originated from Humanigen’s Humaneered® platform, lenzilumab and ifabotuzumab, and HGEN005 are monoclonal antibodies with first-in-class mechanisms. Lenzilumab targets GM-CSF. It is in development as a potential biologic therapy to make CAR-T therapy safer and more effective, as well as a potential treatment for hematologic cancers.
Ifabotuzumab targets the Eph type-A receptor 3 (EphA3). It is being explored as a potential treatment for glioblastoma multiforme (GBM) and a range of solid tumors, as an optimized naked antibody and as part of an antibody-drug conjugate, and also as a backbone for a novel CAR-T construct, and a bispecific antibody platform.
HGEN005 selectively targets the eosinophil receptor EMR1. It is being explored as a potential treatment for a range of eosinophilic diseases. This includes eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct.
In November, Humanigen announced that two abstracts supporting development of its next generation EphA3-CAR-T program were accepted for presentation at the 2019 annual meeting of the Society for Neuro-Oncology (SNO), which took place November 20-24, 2019 in Phoenix, Arizona. The Phase I clinical study, led by Prof. Hui Gan and Prof. Andrew Scott from the Olivia Newton-John Cancer Research Institute in Melbourne, Australia, was funded by the Cure Brain Cancer Foundation.
The study used radiolabeled ifabotuzumab followed by sequential positron emission tomography (PET) imaging to determine biodistribution, frequency of in situ EphA3 expression and quantitative tumor uptake of ifabotuzumab. The preliminary results include data from eight patients who have been enrolled to date.
PET/computed tomography (CT) imaging showed that ifabotuzumab is effectively delivered across the blood-tumor barrier. It accumulates specifically at the tumor site in all patients treated to date with no observed normal tissue uptake. Magnetic resonance imaging (MRI) scans showed predominant T2/FLAIR changes, consistent with the treatment effect of ifabotuzumab on tumor vasculature. Treatment emergent adverse events were readily managed with increased premedications after the initial occurrence.
Humanigen, Inc. (HGEN), closed Thursday's trading session at $0.46, off by 8.00%, on 8,000 volume with 6 trades. The average volume for the last 3 months is 2,456 and the stock's 52-week low/high is $0.400000005/$1.54400002.
Sonoma Pharmaceuticals, Inc. (SNOA)
Zacks, Stock Twits, Whale Wisdom, last10k, Morningstar, InvestorsHub, StockInvest.us, Macrotrends, Dividend Investor, Market Chameleon, Stock Split History, Market Exclusive, Street Insider, GlobeNewswire, Nasdaq, and Simply Wall St reported earlier on Sonoma Pharmaceuticals, Inc. (SNOA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company headquartered in Petaluma, California. It develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. Its products sell throughout the United States and globally. The Company previously went by the name Oculus Innovative Sciences, Inc. It changed its name to Sonoma Pharmaceuticals, Inc. in December of 2016.
Sonoma Pharmaceuticals has manufacturing operations in the United States and Latin America. The Company’s European marketing and sales are headquartered in Roermond, Netherlands.
Sonoma’s products have improved outcomes for greater than six million patients around the world through reducing infections, itch, pain, scarring, as well as harmful inflammatory responses. The Company is the international leader in Hypochlorous Acid (HOCl) based health care solutions. Sonoma began with HOCl based products for wound care patients. After much success helping millions of patients, the Company has since expanded into dermatology, eye care, and animal health.
Sonoma Pharmaceuticals has pioneered the use of HOCl in the specialty pharmaceutical sector. It develops safe and effective healthcare solutions. Its chief emphasis is developing unique solutions for dermatological conditions, eye care and advanced tissue care.
Last month, Sonoma Pharmaceuticals announced financial results for Q2 and six months ended September 30, 2019. Total Revenue of $4,968,000 for Q2 ended September 30, 2019, grew by $29,000, or 1 percent, from $4,939,000 for the same period the year prior. Product Revenues of $4,712,000 million for Q2 ended September 30, 2019, were up by 2 percent, or $77,000, versus $4,635,000 in the same period last year.
Net Loss for the three months ended September 30, 2019 of $1,203,000 decreased by $1,617,000, or 57 percent, versus a Net Loss of $2,820,000 for the three months ended September 30, 2018. As of September 30, 2019, the Company had cash and cash equivalents of $3,232,000.
Total Revenues for the six months ended September 30, 2019 of $9,679,000 rose by $371,000, or 4 percent, versus $9,308,000 for the six months ended September 30, 2018. Product Revenues for the six months ended September 30, 2019 of $9,097,000 rose by $367,000, or 4 percent, versus $8,730,000 for the six months ended September 30, 2018. Net Loss for the six months ended September 30, 2019 of $488,000 decreased by $5,790,000, versus a Net Loss of $6,278,000 for the six months ended September 30, 2018.
Sonoma Pharmaceuticals, Inc. (SNOA), closed Thursday's trading session at $4.013, up 1.5949%, on 18,839 volume with 91 trades. The average volume for the last 3 months is 11,395 and the stock's 52-week low/high is $3.32999992/$10.3500003.
Star Navigation Systems Group Ltd. (SNAVF)
Hot Stocked, GuruFocus, Research Pool, Micro Small Cap, Nasdaq, InvestorX, Street Insider, Wallet Investor, TMXmoney, Morningstar, 4-Traders, TradingView, Stockhouse, GlobeNewswire, and InvestorsHub reported previously on Star Navigation Systems Group Ltd. (SNAVF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Star Navigation Systems Group Ltd. owns the exclusive international license to its proprietary, patented In-flight Safety Monitoring System, STAR-ISMS®, the core of the STAR-A.D.S. ® and of the STAR-ISAMM™ Systems. The Company develops, markets, and promotes In-Flight Safety Monitoring Systems (ISMS) globally. Its real-time capability of tracking performance trends and predicting incident-occurrence enhances aviation safety and improves fleet management. It does so while lessening costs for the operator. Star Navigation Systems has its corporate headquarters in Brampton, Ontario.
The OTCQB-listed Company’s subsidiary, Star-Isoneo, Inc., is a specialized software firm. Star-Isoneo develops complex solutions in engineering, simulation and development for Canadian customers. Star-Isoneo works closely with Star Navigation Systems in the development of the Company’s MEDEVAC (STAR-ISAMM™ and STAR- LSAMM™) applications of the patented STAR-A.D.S. ® technology, and on its present research and development (R&D) program with Bombardier, Inc.
Star Navigation’s M.M.I. Division designs and manufactures high performance, mission critical, flight deck flat panel displays for defence and commercial aviation industries worldwide. For example, these displays are found on aircraft and simulators, from C-130 aircraft, to Sikorsky and Agusta Westland helicopters.
Star Navigation Systems (with capabilities in Flat Panel Displays) provides its customers, OEMs (original equipment manufacturers) and operators, advanced, reliable and proven technologies to modernize their aircraft, helicopters and other vehicles. Star’s technologies support commercial and military aviation, search and rescue operations, and naval applications.
Concerning Medical Evacuation Vehicles, applied to Emergency Medical Services vehicles and environment and MEDEVAC platforms, STAR-A.D.S.™ will ensure real time transmission of critical bio data for speedier and safer dispatch and support to patients. In addition, pertaining to Commercial and Military Aircraft: STAR-A.D.S.™, embedded in the Company’s systems, is global real time tracking for safer aircraft operations, and meeting today the recommendations of ICAO, IATA, and the NTSB for the future of Aircraft Tracking and Safety.
In September, Star Navigation Systems announced that it entered into a partnership and industrial agreement with ANTAZ Technologies Pvt. Ltd, (Antaz). Antaz is a well-established Indian company with facilities in Hyderabad, Bangalore and Delhi, India. Antaz will adapt, integrate, as well as market Star Navigation Systems products to the Indian Defence Forces (Air Force and Navy) in collaboration with Hindustan Aeronautics Limited (HAL). Star is already listed as a registered supplier to HAL for military equipment.
Recently, Star Navigation Systems announced the granting of a new Supplemental Type Certification (STC) to the Company by Transport Canada. The STC relates to the use of the STAR-A.D.S. ® Gen 3 system on an Airbus A320 aircraft type. The STC will allow Star Navigation to install its STAR-A.D.S. ® Gen 3 System on-board the next available AlMasria Universal Airlines aircraft.
Viraf Kapadia, Star Navigation Systems’ Chief Executive Officer, said, “This additional STC adds to our growing list of certifications for commercial and business aircraft. We already had an STC for the previous STAR-A.D.S. ® Gen 2 model. Now the Gen 3 is also A 320 certified and we can offer even more flexibility to an operator, adding GSM communications and manual retrieval through USB port.”
Star Navigation Systems Group Ltd. (SNAVF), closed Thursday's trading session at $0.0638, up 219.00%, on 26,666 volume with 3 trades. The average volume for the last 3 months is 1,176 and the stock's 52-week low/high is $0.0108/$0.0643.
Notox Technologies Corp. (NTOX)
Penny Stock Hub, Last10k, Stock Target Advisor, PredictWallStreet, Wallstreet Online, Market Exclusive, Stockopedia, Investors Hangout, Wallet Investor, Market Screener, Stockwatch, TradingView, Stockhouse, and Simply Wall St reported beforehand on Notox Technologies Corp. (NTOX), and we also report on the Company, here at the QualityStocks Daily Newsletter.
A Nevada corporation, Notox Technologies Corp. focuses on developing and commercializing innovative technologies. It is doing so mainly through its wholly-owned Nevada subsidiary Notox Bioscience, Inc. The Company is working to market a credible, non-toxic alternative to Botox and then develop other features of its Notox technology, including drug-free pain management, body countering, skin tightening and anti-perspiration. Notox Technologies lists on the OTC Markets Group’s OTCQB. The Company has its corporate headquarters in Richmond Hill, Ontario.
Additionally, Notox Technologies is working to build its distribution capabilities for other medical and aesthetic products worldwide. This past February, the Company announced that it entered into a relationship with the Veterans Global Initiative Foundation. This relationship to raise capital for the testing, development, as well as commercialization of Notox’s drug-free pain management solutions, chiefly for the benefit of military veterans who suffer from pain.
Notox Technologies and the VGI Foundation are working together to provide the Notox treatment either at no cost or at deeply discounted rates to those veterans who need relief the most and continue to suffer in cases where other treatments have not worked.
Over the past two years, Notox Technologies has transitioned into developing, commercializing and promoting its patented Notox aesthetic and drug-free pain management platform. This is following the Company’s acquisition of the associated intellectual property (IP) rights in 2016. That patented IP was originally developed by Dr. Frank Papay, MD FACS Chairman Dermatology and Plastic Surgery Institute, Cleveland Clinic, and is owned by The Cleveland Clinic Foundation.
Recently, Notox Technologies announced that it entered into a binding letter of intent (LOI) with Xthetica, Inc., a private Canadian aesthetic and medical beauty distributor, to acquire certain of Xthetica's assets in consideration for the issuance of shares and warrants of Notox Technologies to the sole shareholder of Xthetica, Mr. Manny Kapur. Those assets include Xthetica's rights and obligations under a series of distribution agreements with manufacturers of aesthetic and medical beauty products, access to all of Xthetica's present inventory, as well as the goodwill of Xthetica.
Notox Technologies Corp. (NTOX), closed Thursday's trading session at $3.59, up 99.4334%, on 300 volume with 3 trades. The average volume for the last 3 months is 1 and the stock's 52-week low/high is $1.80009996/$4.50.
FieldPoint Petroleum Corp. (FPPP)
Stock Twits, OTC Markets, Equity Clock, Investing Note, InvestorsHub, Investors Hangout, Real Investment Advice, Market Screener, Wallet Investor, MarketWatch, The Street, and Street Insider reported earlier on FieldPoint Petroleum Corp. (FPPP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
FieldPoint Petroleum Corp. engages in the acquisition, development, and operation of oil and natural gas properties in the U.S. The Company engages in oil and natural gas exploration, production, and acquisition, primarily in Louisiana, New Mexico, Oklahoma, Texas, and Wyoming. FieldPoint Petroleum has its corporate office in Austin, Texas. The Company lists on the OTC Markets’ OTCQB.
Currently, FieldPoint has varying ownership interests in 480 gross producing wells (96 net) in the above-mentioned States. The Company’s strategy centers on expanding its reserve base. This is while increasing production and cash flow through the acquisition of leasehold interests and producing oil and gas wells.
FieldPoint Petroleum has more recently chosen to concentrate on promising areas for oil & gas exploration. These areas include the Lusk Field in Lea County, New Mexico, and the Company’s Ranger Project in the Taylor Serbin Field near Giddings, Texas.
In projects such as these, FieldPoint Petroleum partners with companies that complement internal expertise in evaluating opportunities and in making investment decisions. Regarding producing oil & gas properties, FieldPoint operates 19 wells. Independent contractors operate the other wells per standard industry contracts.
In Wyoming, FieldPoint is active in Converse County and Campbell County. The Company is active in Lea County, Chaves County, and Eddy County in New Mexico. In Texas, FieldPoint is active in Andrews County, Midland County, and Lee & Bastrop Counties. In Louisiana, it is active in Caddo Parrish. In Oklahoma, the Company is active in Grady County and Pontotoc County.
Concerning operated wells, FieldPoint’s portfolio includes mainly low-touch, “pumper and electricity-only” wells in the Devonian, Ellenberger, and Morrow areas of West Texas and New Mexico. Higher maintenance fields are closer to home. These include the Taylor Serbin field near Giddings, Texas. Most of FieldPoint’s production comes from its East Lusk and Serbin Fields.
This past November, FieldPoint Petroleum announced financial results for the third fiscal quarter ended September 30, 2018. Mr. Phillip Roberson, President and Chief Financial Officer, said, "Revenues were down year over year due primarily to the sale of our Apache Bromide production, which occurred in 2017. The Apache Bromide was a high operating cost asset that did not contribute significantly to the bottom line. We did not have a similar sale in 2018, although we are considering that possibility in the future. I am pleased to announce that we have been able to extend our forbearance agreement with Citibank until March 31, 2019, giving us some latitude to evaluate and consider merger, acquisition, and financing opportunities that have been difficult to pursue under a shorter forbearance period."
FieldPoint Petroleum Corp. (FPPP), closed Thursday's trading session at $0.032, up 45.4545%, on 17,805 volume with 6 trades. The average volume for the last 3 months is 6,694 and the stock's 52-week low/high is $0.020999999/$0.200000002.
Select Sands Corp. (SLSDF)
Investors Hangout, Wallet Investors, Penny Stock Hub, Wall Street Analyzer, Investopedia, Stock Gumshoe, Amigo Bulls, Tip Ranks, YCharts, Marketbeat, The Street, InvestorsHub, Stockhouse, TradingView, Zacks, Penny Stock Tweets, MarketWatch, Simply Wall St, Marketwired, Barchart, and OTC Markets reported on Select Sands Corp. (SLSDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Select Sands Corp. is an industrial Silica Product company listed on the OTCQX. The Company is developing its 100 percent owned, 520-acre Northern White, Tier-1, silica sands project located in the State of Arkansas. The Company previously went by the name La Ronge Gold Corp. It changed its name to Select Sands Corp. in November of 2014. The Company has its corporate office in Vancouver, British Columbia.
Silica Sand is quartz that over time, through the work of water and wind, has been broken down into tiny granules. Commercial Silica Sand is extensively used as a proppant by oil and gas companies. Furthermore, it is used in industrial processing. Whole Grain and Ground Silica products range in size, distributions, grain shapes, as well as chemical purity.
The Company’s Sandtown project has NI 43-101 (National Instrument 43-101) compliant Indicated Mineral Resources of 42.0MM tons (TetraTech Report; February 2016). Bell Farm has Inferred Mineral Resources of 49.6MM tons (Kleinfelder Report; April 2017). Both deposits are considered Northern White finer-grade sand deposits of 40-70 Mesh and 100 Mesh.
Select Sands has its Ozark Operations in Arkansas. This property is underlain by the Ordovician St. Peter sandstone formation, the source of premier industrial silica sand ‘Ottawa White’ frac sand. The Company entered into a binding Letter of Agreement for an option to acquire a 100 percent undivided right, title, and interest in the roughly 520-acre premium grade industrial silica sand/frac sand project in northeast Arkansas. The Arkansas project is strategically situated to supply sand to major U.S. oil & gas and Industrial & Specialty markets.
On October 18, 2018, Select Sands announced it placed certain employees at its Arkansas operations on temporary furlough until further notice. Shipments and limited production continue. The Company is pursuing additional opportunities. This includes evaluating sand production and sand-related business opportunities in or near other basins.
Recently, Select Sands announced that it sold 80,000 tons of frac and industrial sands during Q3 2018. This is within its previous guidance of between 65,000 to 95,000 tons.
Zig Vitols, President and Chief Executive Officer of Select Sands, stated, “Sales continue through the quarter and are being supported with appropriate production. Much of the operations are running on single shift to insure optimum control of overhead. As a result, the company has maintained its cash position similar to that reported at the end of Q2. We believe the mid to long-term outlook for demand fundamentals will see a return of stronger shipments of the company’s products.”
Select Sands Corp. (SLSDF), closed Thursday's trading session at $0.0274, up 110.7692%, on 976,175 volume with 68 trades. The average volume for the last 3 months is 34,759 and the stock's 52-week low/high is $0.002499999/$0.103100001.
Adama Technologies Corporation (ADAC)
StreetInsider, InvestorsHub, OTC Markets, Morningstar, and Stockhouse reported on Adama Technologies Corporation (ADAC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Adama Technologies Corporation is a Venture Capital Company listed on the OTCQB. It owns, operates, and invests in technology companies and also startups and expansion companies. The Company has a hands-on approach and works to develop the management and leaders around the corporate landscape to transform big ideas into game changing execution in the field. Adama Technologies has its corporate office in Henderson, Nevada.
Adama Technologies has exceptional access to equity lines of credit, equity funds, private investors, incubators, mentor partners and close ties with Fortune 100, 500 and 1000 companies who serve as exit strategies for many of Adama’s investments.
Adama Technologies’ portfolio companies include Alpine Industries and SafeGuard Pii. Its flagship investment is Alpine Industries located in Utah. Alpine specializes in machining and aerospace manufacturing.
This investment and acquisition launches Adama Technologies into the fast expanding field of aerospace technology. Furthermore, it positions Adama with the stability of being a defense contractor for the U.S. military.
Since its establishment in 1974, Alpine Industries has manufactured several hundred aerospace landing gear components and other spare parts. It continues to work as a US government contractor.
Presently, Alpine holds more than 15 US Military contracts. Most of these contracts are with the US Air Force. Alpine Industries also manufactures parts for a number of private companies. These include parts for drilling components utilized in oil and water wells, roller-coasters, motorcycles, zip line parts, crash pads, as well as drilling carts.
SafeGuard Pii is an industry pioneer and top-tier Privacy Management Firm. It provides compliance solutions to companies across the United States. In addition, SafeGuard Pii is the provider of a strong identity theft protection and restoration product.
The Company’s PII Defender program monitors internet black market sites, other internet trading sites where ID thieves buy and sell information, utility and phone records, public databases, criminal databases and DMV records, plus credit files for one’s personal information.
Recently, Adama Technologies announced that it was accepted and successfully up-listed to the OTCQB marketplace with OTC Markets. Adama had outlined a course towards growth and development. This path included development of additional revenue streams, growing revenues within their present operations, and up-listing into the QB Marketplace.
In addition, this week, Adama Technologies announced that the Company will bid on an additional $3,000,000 in new government contracts with at least $2,000,000 of that number being for US Military Defense contracts. Adama detailed its month-of-March bidding plan and strategy and its optimism concerning its ability to win these contracts. As the bidding process is underway, Adama Technologies will continue to look for additional revenue opportunities in its commercial and retail outlets.
Adama Technologies Corporation (ADAC), closed Thursday's trading session at $0.0004, up 100.00%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 143,384 and the stock's 52-week low/high is $0.000099999/$0.004999999.
Sunset Island Group, Inc. (SIGO)
MicrocapVoice, PennyStockSpy, OTCPicks, and 007 Stock Chat reported earlier on Sunset Island Group, Inc. (SIGO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Sunset Island Group, Inc. provides consulting and advisory services to clients operating in the medical marijuana business space. The Company concentrates on providing a licensed manufacturing facility to clients for producing products, including oils and edibles. Sunset Island Group has its corporate office in San Clemente, California.
The Company’s vision is to establish a fully integrated business, which provides turnkey solutions to the medical cannabis industry. Its primary emphasis is on providing a licensed facility where companies can manufacture and produce their products. In addition, Sunset Island will provide distribution for companies via an established network of dispensaries.
Sunset Island Group earlier secured a lease on a property approved for cannabis cultivation. The Company for permits for 22,000 square feet of green house space. The expectation is that the 22,000 square feet of green house space will be able to produce up to 4,000 pounds of medical cannabis each year.
Sunset Island announced last year that it initiated development of a CBD dietary supplement product. The initial product will feature a 2-oz stress relief beverage made from highest quality legal Hemp/CBD oil and real fruit.
Sunset Island will continue to develop products that will address the demands in the worldwide dietary supplements market. This market is targeted to soon reach greater than $200 billion. The product will undergo development by a trained French Chef with more than two decades of experience in Product Development and Food Production.
Sunset Island Group is performing a retrofit to its current grow space that will considerably increase the amount of cannabis product produced with each harvest. Furthermore, the Company announced in November 2017 that it commenced an aggressive expansion of its cannabis product line.
The Company’s retro fit is two phases. Phase 1 is the retro fit of the present greenhouse operations. Phase 2 is the constructing of a new greenhouse on its bare land or retrofitting another greenhouse on the property.
The aim of the retro fit for Phase 1 is to increase the growable space in the current greenhouse to about 22,000 (with a vertical grow) with roughly 85 percent being canopy space (or around 19,000 square feet). The Company's objective is to yield 0.08-0.10 pounds per growable space and to have five harvests.
Sunset Island Group has received its temporary licenses from the State of California for Distribution, Cultivation and Manufacturing. The licenses are for Adult Use (Recreational) and Medicinal. The licenses permit Sunset Island to sell and transport its own product to dispensaries across California.
The manufacturing license allows it to start manufacturing products such as vape cartridges, edibles, as well as extracts. At present, Sunset Island is in the process of converting one of its cold storage rooms into a clean room to commence manufacturing these products.
Sunset Island Group, Inc. (SIGO), closed Thursday's trading session at $0.24, up 100.00%, on 5,150 volume with 3 trades. The average volume for the last 3 months is 3,620 and the stock's 52-week low/high is $0.05/$0.419999986.
Cavitation Technologies, Inc. (CVAT)
CRWEFinance, MicroStockProfit, Hotstocked, Stock Preacher, Stockwire, ActivePennyStock, PennyStocks24, PennyStockWatchman, UndiscoveredEquities, Beacon Equity Research, MicrocapVoice, CRWEWallStreet, DrStockPick, and PennyOmega reported on Cavitation Technologies, Inc. (CVAT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cavitation Technologies, Inc. designs and manufactures state-of-the-art, flow-through, devices and systems. Furthermore, it develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algae oil extraction, alcoholic beverage enhancement, and water treatment. Established in 2007, Cavitation Technologies is based in Chatsworth, California.
Desmet Ballestra Group, S.A. has been the Company’s strategic partner since 2010. Cavitation Technologies has commercialized its patent-pending CTi Nano Neutralization® process. It provides the refiners of edible oils and fats significant yield improvements, major cost savings, as well as environmental benefits.
Desmet Ballestra Group has partnered with Cavitation Technologies to market this ground-breaking technology globally to large-scale facilities. Desmet Ballestra Group is the foremost worldwide solutions provider for the edible oil and fats and biodiesel industries.
Cavitation Technologies is a pioneering leader in processing liquids, fluidic mixtures, emulsions, and suspended solids. As an add-on to its existing neutralization systems, the Company’s patented NanoReactor™ enables refiners to considerably lessen processing costs and environmental impact. This is while also improving yield.
The Company’s core technology includes the use of hydrodynamic cavitation. Cavitation can be of different origins. These origins include acoustic (typically, ultrasound-induced), hydrodynamic or generated with laser light, accelerated particles, an electrical discharge or steam injection.
Cavitation’s technologies can be applied to a number of other fluid-processing industries, which will benefit from increased yields, reduced processing costs, and improved quality. The Company has filed patent applications related to edible oil refining, algal oil extraction, renewable fuel production, alcoholic and non-alcoholic beverage processing and enhancement, water treatment and purification, and petroleum upgrading.
In November, Cavitation Technologies announced it received a purchase order from Desmet Ballestra Group. Cavitation’s Nano Reactor™ is to be installed at a new vegetable oil refinery with daily capacity of 900 metric tonnes per day (MTPD). This represents the first purchase order Cavitation received in China. The expectation is that the system shipment will be completed in the Company's fiscal Q2 2018.
Cavitation Technologies, Inc. (CVAT), closed Thursday's trading session at $0.028, up 40.00%, on 12,200 volume with 2 trades. The average volume for the last 3 months is 148,159 and the stock's 52-week low/high is $0.0103/$0.037500001.
The QualityStocks Company Corner
- Predictive Oncology (NASDAQ: POAI)
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
- HTC Extraction Systems (TSX.V: HTC)
- Sharing Services Global Corporation (SHRG)
- Spectrum Global Solutions, Inc. (SGSI)
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)
- Sigma Labs Inc. (NASDAQ: SGLB)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- ChineseInvestors.com (CIIX)
- No Borders Inc. (OTC: NBDR)
- SinglePoint, Inc. (SING)
- LiveWire Ergogenics Inc. (OTC: LVVV)
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology (NASDAQ: POAI), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced its receipt of interest from several parties for the possible acquisition of its Skyline Medical division, which produces and sells the STREAMWAY System for disposal of fluids in medical applications. Predictive Oncology previously announced intentions to focus its resources on its primary mission of applying artificial intelligence to precision medicine and drug discovery. To view the full press release, visit http://nnw.fm/sC83S. Also today, NetworkNewsWire released a report on the company detailing how the global cancer diagnostics market was valued at $144.4 billion in 2018 and is expected to grow at a 7.0% CAGR over the next six years on the back of increasing prevalence of oncologic cases, rapid technological advancement, and rising demand for effective screening tests. Within this broader cancer market, the Patient Derived Xenograft (PDx) segment, which involves a personalized approach to cancer treatment, was valued at $ 77.4 million in 2017 and is expected to grow at a CAGR of 16.7%, reaching $167.6 million by 2022.
Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.
Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:
- A database of clinically validated historical and outcome data from patient tumors
- An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
- A “smart” patient-derived tumor profiling platform
- An in-house bioinformatics artificial intelligence (AI) platform
- A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
- An FDA-approved fluid collection and disposal system
Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.
Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.
Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.
Predictive Oncology (POAI), closed Thursday's trading session at $3.00, up 6.383%, on 176,609 volume with 817 trades. The average volume for the last 3 months is 20,940 and the stock's 52-week low/high is $2.3499999/$8.50.
- Predictive Oncology Inc. (NASDAQ: POAI) Announces Multiple Indications of Interest for Skyline Medical Division
- Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Tech Primed to Play Key Role in Cancer Drug Development Efforts
- Predictive Oncology Inc.’s (NASDAQ: POAI) Platform Revolutionizing Cancer Treatment
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was highlighted in a publication from Financialnewsmedia.com, examining how for the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a “breakthrough therapy” for the treatment of major depressive disorder (MDD).
Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint.
The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.
In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.
Significant Expansion Plans with Streamlined Licensing Process
Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.
In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.
The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.
Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.
Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products
Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.
Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.
Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.
The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.
Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.
Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.
Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.
Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.
Experienced Executive Team
- CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
- Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
- Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
- Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
- Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.
This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.
1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.
Organigram Holdings Inc. (NASDAQ: OGI), closed Thursday's trading session at $2.62, up 1.9455%, on 2,363,883 volume with 7,361 trades. The average volume for the last 3 months is 2,327,543 and the stock's 52-week low/high is $2.00/$8.43999958.
- US FDA Breakthrough Therapy Designation for Mushrooms Creating Big Opportunity
- Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Announces Establishment of At-The-Market Equity Program
- Why Some People May Cough When They Vape CBD
HTC Extraction Systems (TSX.V: HTC)
HTC Extraction Systems (TSX.V: HTC) was featured today in the 420 with CNW by CannabisNewsWire. The National Credit Union Administration (NCUA) is allowing people previously convicted of drug possession to work at credit unions. In July, the NCUA board announced the proposed changes to their employment regulations, which allows an exception for low-level drug offenders. On Monday, the agency published its ruling in the Federal Register and said that that it examined the comments submitted by the public and that the changes will be enacted into law.
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Thursday's trading session at $0.215, up 4.878%, on 12,500 volume with 2 trades. The average volume for the last 3 months is 129,567 and the stock's 52-week low/high is $0.079999998/$1.24.
- 420 with CNW – Federal Agency Says Those with Drug Convictions Can Work at Credit Unions
- HTC Extraction Systems (TSX.V: HTC) Acquisition Augments Company’s Output Capability
- HTC Extraction Systems (TSX.V: HTC) Advances Toward Equipment Installation at Hemp-Biomass Extraction Facility
Sharing Services Global Corporation (SHRG)
Sharing Services Global Corporation’s (OTCQB: SHRG) Elepreneurs subsidiary has employed an interactive, video-based platform from VERB Technology Inc. to help it continue its significant sales growth in the direct-selling market. The company’s Elepreneurs, or independent sales force, is currently using the VERB platform in the United States, with plans to launch the platform soon in Canada (http://nnw.fm/cB01C).
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Thursday's trading session at $0.115, up 13.8614%, on 25,150 volume with 7 trades. The average volume for the last 3 months is 37,866 and the stock's 52-week low/high is $0.065800003/$0.3944.
- Sharing Services Global Corporation’s (SHRG) Elepreneurs Adopt Interactive, Video-Based Platform to Grow North American Sales
- Sharing Services Global Corporation (SHRG) Well Positioned to Capitalize on Globalization, Diversity Trend in Direct-Selling Space
- Sharing Services Global Corp. (SHRG) Subsidiary Revolutionizing Traditional Direct-Selling Approach
Spectrum Global Solutions, Inc. (SGSI)
Spectrum Global Solutions (OTCQB: SGSI), a leading single-source provider of next-generation communications network, technology, infrastructure and maintenance solutions, recently secured new contract awards totaling over $2.5 million from existing and new clients across all operating subsidiaries to its opportunity pipeline (http://nnw.fm/QJl1a). To view the full article, visit http://nnw.fm/m8hNV.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Thursday's trading session at $0.0325, up 4.8387%, on 26,825 volume with 10 trades. The average volume for the last 3 months is 116,242 and the stock's 52-week low/high is $0.014999999/$0.349999994.
- Spectrum Global Solutions Inc. (SGSI) Increases Opportunity Pipeline with New Contracts
- Spectrum Global Solutions Inc. (SGSI) Quarterly Report Shows Stronger Balance Sheet, Boost from New Contracts and WaveTech Acquisition
- Spectrum Global Solutions Inc. (SGSI) Expands Range of 5G Services with Acquisition of Battery Technology Company
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)
Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. The recently published NCUA (The National Credit Union Administration) notice states that although the board is not overlooking the impact of drug possession and use on public health, the board believes that people previously convicted of simple drug offenses pose less risk to insured credit unions. The notice further states that when drug convictions are handed out on people in disadvantaged communities, they are bound to experience several collateral consequences. NCUA further wrote that people convicted of non-violent drug possession offenses are already suffering from extrajudicial consequences such as employment bans, loss of financial aid, loss of voting rights, they cannot access public housing, and are disqualified from occupational licenses as well as denial of public assistance. It also noted that people of color are the most affected by drug convictions.
Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLPRF), closed Thursday's trading session at $1.25, off by 2.0425%, on 65,074 volume with 86 trades. The average volume for the last 3 months is 46,864 and the stock's 52-week low/high is $1.08749997/$6.00810003.
- 420 with CNW – Federal Agency Says Those with Drug Convictions Can Work at Credit Unions
- CBD Company Partners With Mattress Maker to Create Sleep Aid
- Plus Products Reports Unaudited 2019 Third Quarter Results
Sigma Labs Inc. (NASDAQ: SGLB)
Sigma Labs Inc. (NASDAQ: SGLB) announces the availability of a broadcast titled, “Unleashing the Disruptive Forces of 3D Printing.” To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/1T7jm. To read the full editorial, visit: http://nnw.fm/g3zSt.
Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.
For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.
Revolutionizing Additive Manufacturing
Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.
Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.
Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.
Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.
Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.
Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.
Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.
Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.
Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.
John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.
Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.
CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.
Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.
Sigma Labs Inc. (SGLB), closed Thursday's trading session at $1.10, off by 0.900901%, on 62,953 volume with 231 trades. The average volume for the last 3 months is 188,820 and the stock's 52-week low/high is $0.451099991/$2.46000003.
- Sigma Labs Featured in Discussion of Full Promise of 3D-Printing Technology
- Sigma Labs, Inc. (NASDAQ: SGLB) Names Seasoned Software Executive as Executive Chairman
- Sigma Labs Inc. (NASDAQ: SGLB) Releases Q3 Numbers, Remains at the Forefront of Next Industrial Revolution
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted in a publication from Financialnewsmedia.com, examining how, for the second year, the U.S. FDA designated psilocybin, a compound found in hallucinogenic mushrooms, as a “breakthrough therapy” for the treatment of major depressive disorder (MDD).
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed Thursday's trading session at $0.638, off by 1.269%, on 691,835 volume with 393 trades. The average volume for the last 3 months is 1,339,051 and the stock's 52-week low/high is $0.469300001/$4.38000011.
- US FDA Breakthrough Therapy Designation for Mushrooms Creating Big Opportunity
- 420 with CNW – Campaigners Urge EU to Adopt Medical Marijuana Standards Like Germany’s
- CBD Company Partners With Mattress Maker to Create Sleep Aid
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted in a publication from Financialnewsmedia.com, examining how, while several headlines have cropped up in the last few months about the dangers of vaping, that hasn’t stopped the cannabis sector from pressing ahead on developing new vape products in the lead-up to the December 16th sales launch date in Canada. Also today, CannabisNewsWire released a report on the company covering today’s provided operational update on SPRWF’s focused infrastructure that serves dedicated functions from seed to sale. Per the update, the company leased its manufacturing, processing and packaging facility located in Kitchener, Ontario (“Supreme Cannabis Kitchener”) in response to internal requirements and foreseeable market demand. Additionally, SPRWF has announced the appointment of a new senior vice president of commercial (http://cnw.fm/XWt6G ). With more than two decades of regulated industry expertise under his belt, including experience working in the cannabis space, Joel Toguri is well suited to further strengthening the SPRWF executive team.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Thursday's trading session at $0.48, off by 2.0408%, on 336,687 volume with 244 trades. The average volume for the last 3 months is 546,421 and the stock's 52-week low/high is $0.432000011/$1.7888.
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces New VP to Lead Sales Operations
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Provides Update on Infrastructure that Serves Dedicated Functions from Seed to Sale
- More than 700 New Cartridge-Based Pot Vaping Systems Expected to Hit Market Just in Time for Christmas
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was featured today in a publication from HempWireNews, examining how hemp farmers and companies that sell CBD-infused products can finally heave a sigh of relief after the United States Department of Agriculture (USDA) and the Department of Justice (DOJ) announced that they would take extra steps to ensure the security of interstate hemp shipments. Also today, the company was highlighted in a publication from CBDWire, examining how LXRP is announcing further advances in its proprietary oral drug delivery platform DehydraTECH™, which is innovating edible consumption of nicotine and cannabis products as a quick-response alternative to inhalation.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.41, off by 0.267575%, on 90,840 volume with 54 trades. The average volume for the last 3 months is 94,356 and the stock's 52-week low/high is $0.395900011/$1.6875.
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Makes Edible Drug Delivery Platform Even Faster
- USDA and DOJ in Talks to Ease Hemp Interstate Transport
- Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Drug Delivery Platform Proven to Enhance Absorption of Bioactive Compounds
ChineseInvestors.com (CIIX) was featured today in a publication from CBDWire, examining how cannabidiol (CBD) has achieved what very few products have. From being barely known, CBD has grown so quickly that it is estimated the cannabidiol market will be worth at least $20 billion in sales by 2026. However, there’s a good reason why most new products have to go through a lengthy approval period before hitting the shelves. Especially products that claim to cure a variety of diseases. Also today, the company was featured in a publication from CBDWire, examining how In a recent letter to shareholders, ChineseInvestors.com (OTCQB: CIIX) CEO Warren Wang reported the company’s plans to continue to expand and market its industrial hemp-infused/CBD products in 2020 (http://cnw.fm/K8Tno). To view the full article, visit http://cnw.fm/5tvxI.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.20, off by 5.8713%, on 77,944 volume with 9 trades. The average volume for the last 3 months is 45,375 and the stock's 52-week low/high is $0.165000006/$0.654999971.
- ChineseInvestors.com Inc. (CIIX) CEO Reveals Hemp-Infused/CBD Product Plans for 2020
- UCSD Researchers Study Possible Benefits and Risks of Cannabidiol
- FDA Releases Revised CBD Consumer Update
No Borders Inc. (OTC: NBDR)
No Borders (OTC: NBDR) today announced “qualification” of its Reg A offering with the states of New York and Colorado to offer its up to $3 million capital raise to investors in these states. Per the update, NBDR continues to work with and file for qualification in several additional states and, as those processes move forward, will continue to expand its networking and engagement operations to ensure the highest market visibility and best strategic capital position for the organization. To view the full press release, visit http://cnw.fm/hUwu5. Also today, CryptoCurrencyWire released a report on the company detailing how laboratory CBD- and THC-concentration test results for retail CBD products are now on the blockchain, thanks to No Borders Inc. (OTC: NBDR).
No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.
Different by Design
Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.
The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.
With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.
- No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
- No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
- No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
- No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
- No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.
No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.
COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.
CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.
Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.
No Borders Inc. (NBDR), closed Thursday's trading session at $0.018, off by 30.7692%, on 60,000 volume with 6 trades. The average volume for the last 3 months is 60,237 and the stock's 52-week low/high is $0.007699999/$0.048799999.
- No Borders Inc. (NBDR) Develops, Releases Lab Test Recording Blockchain Platform
- No Borders Inc. (NBDR) Announces Qualification of $3M Reg A Offering in New York and Colorado
- No Borders Inc. (NBDR) Launches Revolutionary Blockchain-Based ‘CBD LabChain’ to Deliver Secure, Transparent and Verified Lab Results
SinglePoint, Inc. (SING)
Investorideas.com, a leading investor news resource covering cannabis and hemp stocks releases a special report looking at the upcoming MJBizCon event in Las Vegas, December 11th-13 and some of the many attending industry leaders and exhibitors expectations, including SinglePoint Inc. (OTCQB: SING).
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Thursday's trading session at $0.01017, off by 3.1429%, on 1,684,218 volume with 66 trades. The average volume for the last 3 months is 2,765,368 and the stock's 52-week low/high is $0.009999999/$0.028799999.
- 420 with CNW – Campaigners Urge EU to Adopt Medical Marijuana Standards Like Germany’s
- MJBizCon 2019 Canna Buzz - Optimism Abounds for 2020 Cannabis Sector
- Solar Revenues For Companies Jump As Firms Diversify Applications And Focus In A Growth Industry On Expanding Roofing Installations, Primarily In California
LiveWire Ergogenics Inc. (OTC: LVVV)
LiveWire Ergogenics (OTC: LVVV) is diligently watching the progress of the SAFE Banking Act, which would permit banks and credit unions to offer financial services to legal cannabis businesses once passed by the Senate. To view the full article, visit http://cnw.fm/sWeJ2.
LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.
During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:
PODs and Distribution in Coachella, California
For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.
Estrella Ranch in Paso Robles, California
Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.
The Paso Robles Nursery
LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.
LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.
GHC Ventures Subsidiary
GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.
GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.
LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.
LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.
7X Pure™ Dosing and Verification System
LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.
The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.
The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.
Acquisitions & Operations
To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.
Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.
The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.
LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.
LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.
Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.
As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.
Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.
Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.
Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.
Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.
Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.
LiveWire Ergogenics Inc. (OTC: LVVV), closed Thursday's trading session at $0.005876, off by 1.5745%, on 216,456 volume with 10 trades. The average volume for the last 3 months is 1,198,581 and the stock's 52-week low/high is $0.0035/$0.037399999.
- LiveWire Ergogenics Inc. (LVVV) Set to Benefit Upon Senate Passing SAFE Banking Act Legislation
- Senate Minority Leader Asks USDA to Extend Hemp Comments Period
- LiveWire Ergogenics Inc. (LVVV) Takes Unique ‘Family-Farm Style’ Approach to Cannabis Industry
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Enthusiastic International Reception of “AR Glow” Product at China Import and Export Fair
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Cannabis Strategic Ventures, Inc. (NUGS) Projects Escalating Sales Through Year End, Expects 2020 Revenues to Exceed $5M
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Wisconsin Governor Signs Hemp Production Bill
- ChineseInvestors.com (CIIX) FDA Releases Revised CBD Consumer Update
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Announces Closing of First Tranche of Private Placement
- CloudCommerce (OTCQB: CLWD) Benefiting from Dramatic Transition to Digital Advertising
- Dama Financial - Product Integration With PayWana Set to Revolutionize Retail Checkout Processing
- Endonovo Therapeutics (OTCQB: ENDV) Revenues Up 153% in Q3, SofPulse® Already Successfully in Use at Over 30 Medical Facilities Nationwide
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Present at Upcoming LD Micro Main Event
- Genprex, Inc. (NASDAQ: GNPX) New Era of Gene Therapy
- GP Solutions (GWPD) Featured in Article Discussing Controlled Environment Micro-Farms as Partial Solution Amidst Recent E. Coli Outbreak
- Grapefruit Boulevard Investments Inc. (IGNG) Announces Completion of GBI Audit, Super 8-K Filing
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) CBD Companies Say Lack of FDA Rules is Hurting Their Businesses
- Green Hygienics Holdings Inc. (OTC: GRYN) Names New Head of Quality and Compliance
- Hemptown USA - Aims to Capitalize on Mounting CBG Market
- HTC Extraction Systems (TSX.V: HTC) Acquisition Augments Company’s Output Capability
- InsuraGuest Inc. - Sees New Landscape of Opportunity as Vacation Rental Market Booms
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Awareness of CBD Grows in Europe/a>
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) DehydraTECH™ Drug Delivery Platform Proven to Enhance Absorption of Bioactive Compounds
- LiveWire Ergogenics Inc. (OTC: LVVV) Takes Unique ‘Family-Farm Style’ Approach to Cannabis Industry
- Marijuana Company of America Inc. (MCOA) Here Are the Details of Annual US Hemp Imports
- MCTC Holdings Inc. (MCTC) Designers Compete to Portray Hemp as the Material For the Future
- Neutra Corp. (OTCQB: NTRR) Senate Minority Leader Asks USDA to Extend Hemp Comments Period
- No Borders Inc. (OTC: NBDR) Launches Revolutionary Blockchain-Based ‘CBD LabChain’ to Deliver Secure, Transparent and Verified Lab Results
- Nightfood, Inc. (OTCQB: NGTF) Secures Distribution Commitment from Additional Top-10 Supermarket Chain
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Announces Establishment of At-The-Market Equity Program
- ORHub Inc. (ORHB) Secures Account with Another New Surgical Spotlight Customer
- OriginClear (OCLN) CEO Projects ‘Amazing’ Year as Company Looks to Worldwide Growth in 2020
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Reports Unaudited 2019 Third Quarter Results
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Completion of Automation, Strategic Account Payment Structure With Valkor Oil and Gas and Appoints New Advisory Board Member
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) CBD Company Partners With Mattress Maker to Create Sleep Aid
- Predictive Oncology Inc. (NASDAQ: POAI) Platform Revolutionizing Cancer Treatment
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
- Quest Patent Research Corp. (QPRC) Actively Harvesting IP Asset Portfolio
- Sharing Services Global Corporation (SHRG) Well Positioned to Capitalize on Globalization, Diversity Trend in Direct-Selling Space
- Sigma Labs, Inc. (NASDAQ: SGLB) Names Seasoned Software Executive as Executive Chairman
- SinglePoint, Inc. (SING) Solar Revenues For Companies Jump As Firms Diversify Applications And Focus In A Growth Industry On Expanding Roofing Installations, Primarily In California
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Brokered Private Placement of up to CDN$10 Million in Unsecured Convertible Debentures
- Spectrum Global Solutions, Inc. (SGSI) Quarterly Report Shows Stronger Balance Sheet, Boost from New Contracts and WaveTech Acquisition
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Executes Its First Provincial Supply Agreement with Alberta
- SRAX Inc. (NASDAQ: SRAX) Bolsters BIGtoken’s Entry into Market Research Through Partnership with Top Insights Exchange Platform Cint
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Entering Commissioning Phase of its First-of-a-Kind Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Employs Aggressive Merger and Acquisition Roll-Up Strategy
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Launches New CBD Product as New Senior Executives Join the Team -- CFN Media
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) CBD Company Partners With Mattress Maker to Create Sleep Aid
- Trxade Group Inc. (TRXD) Subsidiary Launches Unique Health Hubs with Benzer Pharmacy Chain
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – How Marijuana Can Improve Your Holidays
- VPR Brands, LP (VPRB) 420 with CNW – How Marijuana Can Improve Your Holidays
- Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Commence Trading on the Toronto Stock Exchange on December 5
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Low-Risk Content Production Approach Provides Consistent Revenue Stream
- Xalles Holdings Inc. (XALL) Maintains Nimble Fintech Profile Amid Crypto Volatility
- Youngevity International, Inc. (NASDAQ: YGYI) Why Some People May Cough When They Vape CBD
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.